The Journal of General Physiology
Scientifica: Experts in Electrophysiology
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online Jun 26 2006. doi:10.1085/jgp.200609507
The Rockefeller University Press, 0022-1295 $8.00
JGP, Volume 128, Number 1, 73-87
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 759K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JGP
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Angermann, J. E.
Right arrow Articles by Greenwood, I. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Angermann, J. E.
Right arrow Articles by Greenwood, I. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Mechanism of the Inhibition of Ca2+-Activated Cl Currents by Phosphorylation in Pulmonary Arterial Smooth Muscle Cells



Jeff E. Angermann1, Amy R. Sanguinetti1, James L. Kenyon2, Normand Leblanc1, and Iain A. Greenwood3

1 Department of Pharmacology and 2 Department of Physiology and Cell Biology, Center of Biomedical Research Excellence (COBRE), University of Nevada School of Medicine, Reno, NV 89557
3 Division of Basic Medical Sciences, St George's, University of London, London, SW17 0RE UK

Correspondence to Iain A. Greenwood or Normand Leblanc: grenwood{at}sgul.ac.uk or NLeblanc{at}unr.edu

The aim of the present study was to provide a mechanistic insight into how phosphatase activity influences calcium-activated chloride channels in rabbit pulmonary artery myocytes. Calcium-dependent Cl currents (IClCa) were evoked by pipette solutions containing concentrations between 20 and 1000 nM Ca2+ and the calcium and voltage dependence was determined. Under control conditions with pipette solutions containing ATP and 500 nM Ca2+, IClCa was evoked immediately upon membrane rupture but then exhibited marked rundown to ~20% of initial values. In contrast, when phosphorylation was prohibited by using pipette solutions containing adenosine 5'-(ß,{gamma}-imido)-triphosphate (AMP-PNP) or with ATP omitted, the rundown was severely impaired, and after 20 min dialysis, IClCa was ~100% of initial levels. IClCa recorded with AMP-PNP–containing pipette solutions were significantly larger than control currents and had faster kinetics at positive potentials and slower deactivation kinetics at negative potentials. The marked increase in IClCa was due to a negative shift in the voltage dependence of activation and not due to an increase in the apparent binding affinity for Ca2+. Mathematical simulations were carried out based on gating schemes involving voltage-independent binding of three Ca2+, each binding step resulting in channel opening at fixed calcium but progressively greater "on" rates, and voltage-dependent closing steps ("off" rates). Our model reproduced well the Ca2+ and voltage dependence of IClCa as well as its kinetic properties. The impact of global phosphorylation could be well mimicked by alterations in the magnitude, voltage dependence, and state of the gating variable of the channel closure rates. These data reveal that the phosphorylation status of the Ca2+-activated Cl channel complex influences current generation dramatically through one or more critical voltage-dependent steps.


Abbreviations used in this article: AMP-PNP, adenosine 5'-(ß,{gamma}-imido)-triphosphate; PSS, physiological salt solution.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
W. Liang, J. B. Ray, J. Z. He, P. H. Backx, and M. E. Ward
Regulation of Proliferation and Membrane Potential by Chloride Currents in Rat Pulmonary Artery Smooth Muscle Cells
Hypertension, August 1, 2009; 54(2): 286 - 293.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Rock, W. K. O'Neal, S. E. Gabriel, S. H. Randell, B. D. Harfe, R. C. Boucher, and B. R. Grubb
Transmembrane Protein 16A (TMEM16A) Is a Ca2+-regulated Cl- Secretory Channel in Mouse Airways
J. Biol. Chem., May 29, 2009; 284(22): 14875 - 14880.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. C. Hartzell, K. Yu, Q. Xiao, L.-T. Chien, and Z. Qu
Anoctamin/TMEM16 family members are Ca2+-activated Cl\#8722; channels
J. Physiol., May 15, 2009; 587(10): 2127 - 2139.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. E. O'Driscoll, W. J. Hatton, H. R Burkin, N. Leblanc, and F. C. Britton
Expression, localization, and functional properties of Bestrophin 3 channel isolated from mouse heart
Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1610 - C1624.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
R. Bao, L. M. Lifshitz, R. A. Tuft, K. Bellve, K. E. Fogarty, and R. ZhuGe
A Close Association of RyRs with Highly Dense Clusters of Ca2+-activated Cl- Channels Underlies the Activation of STICs by Ca2+ Sparks in Mouse Airway Smooth Muscle
J. Gen. Physiol., July 1, 2008; 132(1): 145 - 160.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. N. Saleh, J. E. Angermann, W. R. Sones, N. Leblanc, and I. A. Greenwood
Stimulation of Ca2+-Gated Cl- Currents by the Calcium-Dependent K+ Channel Modulators NS1619 [1,3-Dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one] and Isopimaric Acid
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1075 - 1084.
[Abstract] [Full Text] [PDF]



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents